Investing.com - Taiwan Liposome ADR reported on Friday fourth quarter earnings that beat analysts' forecasts and revenue that fell short of expectations.
Taiwan Liposome ADR announced earnings per share of $-0.14 on revenue of $551K. Analysts polled by Investing.com anticipated EPS of $-0.1533 on revenue of $640K.
Taiwan Liposome ADR shares are down 6% from the beginning of the year and are trading at $5.41 , down-from-52-week-high.They are under-performing the STOXX 600 which is up 2.61% from the start of the year.
Taiwan Liposome ADR follows other major sector earnings this month
Taiwan Liposome ADR's report follows an earnings beat by Ping An Insurance Company of China on Wednesday, who reported EPS of $0.6777 on revenue of $26.15B, compared to forecasts EPS of $0.5355 on revenue of $24.08B.
Orsted ADR had beat expectations on Wednesday with fourth quarter EPS of $0.2643 on revenue of $2.51B, compared to forecast for EPS of $0.1594 on revenue of $2.67B.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar